Pine Knoll Shores, NC, United States of America

George Edward Sherman, Jr

This inventor holds 1 USPTO granted patent and 1 published patent application. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: George Edward Sherman, Jr. Retrieved from https://idiyas.com/inventor/george-edward-sherman-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: George Edward Sherman, Jr.: Innovator in Biodegradable Implants

Introduction

George Edward Sherman, Jr. is a notable inventor based in Pine Knoll Shores, NC (US). He has made significant contributions to the field of biomedical engineering, particularly in the development of biodegradable implants. His innovative work focuses on improving patient outcomes through advanced formulations.

Latest Patents

Sherman holds a patent for a biodegradable implant that includes naltrexone. This formulation is designed to ameliorate undesirable localized reactions at the site of implantation. His patent represents a significant advancement in the field, addressing common complications associated with traditional implants.

Career Highlights

Throughout his career, Sherman has dedicated himself to research and development in the biomedical sector. His work has led to the creation of solutions that enhance the safety and efficacy of medical implants. With a focus on patient care, he continues to explore new avenues for innovation.

Collaborations

Sherman has collaborated with esteemed colleagues, including Brady J Granier and Ashok Kumar. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further driving innovation in their field.

Conclusion

George Edward Sherman, Jr. is a pioneering inventor whose work in biodegradable implants is making a difference in the medical field. His contributions, particularly in the formulation of naltrexone, highlight the importance of innovation in improving patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…